Post hoc long-term follow-up of the RELIEF trial (1520 analysed after major abdominal surgery): new or worse chronic kidney disease stage ≥3 did not differ with restrictive vs liberal IV fluids (56% vs 53.4%; adjusted OR 1.13, 95% CI 0.91–1.41).
Secondary analysisn = 1,520
McIlroy et al. Perioperative intravenous fluid and chronic kidney disease: long-term follow-up of the Restrictive versus Liberal Fluid Therapy in Major Abdominal Surgery (RELIEF) randomised trial